Search Browse Earnings

BGM Group Ltd. — SlamSEC

BGM Group Ltd.

Nasdaq:BGM

Pharmaceutical Preparations·CHENGDU

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$64.9M

+13.6% YoY

FY 2024

Adj. EBITDA

$3.3M

5.1% margin

FY 2024

Net Income

$1.1M

1.7% margin

FY 2024

EPS (Diluted)

$0.15

FY 2024

Stock Price

$0.99

-5.9%

2026-03-09

52W Range

$0.96 – $17.17

P/E Ratio

6.6x

Market Cap

$35.5M

Cash

$7.5M

FY 2024

Total Debt

—

Net Cash

$7.5M

FY 2024

Enterprise Value

$28.0M

Debt / EBITDA

-2.2x

FY 2024

EV / EBITDA

8.4x

Employees

—